PubMed Health⌕ Search

PubMed · 16174915

Celsius Control system.

Abstract

The Celsius Control system (Innercool Therapies, Inc.) is an intravascular cooling catheter system consisting of the Celsius Control catheter,circulating set, and the Celsius Control console. Based on clinical studies, the system has recently received Food and Drug Administration approval for use as a device to induce, maintain, and reverse mild hypothermia in neurosurgical patients in surgery and recovery/intensive care, and is currently being marketed in the 10.7 Fr and 14 Fr catheter sizes. It works to regulate temperature by circulating sterile saline through the Celsius Control console, which contains an integrated assembly comprising a temperature and pressure sensing block,supply and return lines, and a 20-{m} filter with connective tubing and an independent heat exchanger and pump. The system relies on digital core temperature readings from either esophageal or bladder temperature probes. After the system is turned on, approximately 150 mL of sterile saline solution is pumped through the console and is cooled to achieve the preset temperature. This cooled saline subsequently circulates from the console through the catheter in a closed-loop manner. The distal portion of the catheter incorporates a flexible distal metallic heat transfer element that is designed to allow for direct exchange of thermal energy with blood circulating around the catheter.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Neeraj Badjatia. 2004. Celsius Control system.. https://doi.org/10.1385/ncc%3A1%3A2%3A201

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Is there evidence for recommending needleless closed catheter access systems in guidelines? A systematic review of randomized controlled trials.

A systematic review was conducted to determine whether certain vascular access policies are better than others in terms of prevention of catheter-related infections. Publications were retrieved by a search of Medline, the Cochrane Library and Embase up to May 2005. All randomized trials and systematic reviews/meta-analyses of randomized trials evaluating the effect of vascular access policies (i.e. needleless closed systems, conventional closed systems or conventional open systems) on catheter-related infection in hospitalized patients with intravascular catheters in situ were selected. Two reviewers independently assessed trial quality and extracted data. Data from the original publications were used to calculate the relative risk or the incidence-density relative rate of catheter-related infection. Data for similar outcomes were combined in the analysis where appropriate using a random-effects model. Of the six studies reviewed, one was excluded. Five randomized controlled trials were included in the review. The quality of the trials and the way they were reported were generally unsatisfactory. Four trials compared needleless closed systems with conventional open systems. There was a trend for an advantage of the needleless closed devices in terms of less catheter-associated bloodstream infection, less catheter tip colonization and less hub inlet colonization. There were no possibilities for combining data because of clinical heterogeneity. One trial compared needleless closed systems with conventional closed systems and the evidence was inconclusive. From the point of view of infection prevention, there are no objections to use these new systems. However, there is insufficient evidence at this stage to recommend the needleless closed vascular devices.

Catheterization↗

Role of drug eluting stents in diabetic patients.

There is a clear need for a large multicentre trial comparing the efficacy of the two available drug eluting stents, sirolimus and paclitaxel, in diabetic patients with multivessel disease.

Catheterization↗